Office of Public Affairs | Major Generic Drug Companies to Pay Over Quarter of a Billion Dollars to Resolve Price-Fixing Charges and Divest Key Drug at the Center of Their Conspiracy justice.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from justice.gov Daily Mail and Mail on Sunday newspapers.
Teva, Glenmark Pharmaceuticals admit price fixing, pay $225 Million penalty and Donate $50 Million | Wisconsin Law Journal wislawjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wislawjournal.com Daily Mail and Mail on Sunday newspapers.
It's the latest resolution in a string of cases related to price-fixing, referring to competitors banding together to artificially set the price of a product.
Global Honey Market By Application, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast, 2020 - 2026 benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Aleor’s ANDA for treatment of cutaneous candidiasis gets USFDA nod
April 01, 2021
ANDA is for Nystatin and Triamcinolone Acetonide Cream USP to be marketed in US
Alembic Pharmaceuticals Limited’s joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US drug regulator, US Food & Drug Administration (USFDA), for an Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Cream USP, the company informed.
Aleor is a 60:40 joint venture between Alembic Pharmaceuticals Limited and Orbicular Pharmaceutical Technologies Pvt Ltd (Orbicular) focused on commercialising dermatology products globally.
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/gram, of Taro Pharmaceuticals U.S.A. Inc, an official statement said here.